BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15449150)

  • 61. [Antineoplastic effect of UFT therapy (uracil-FT-207 combination therapy) on experimental pancreatic cancer transplanted in the pancreas and subcutaneous region].
    Ohyama K; Koike D; Odake Y; Takiyama Y; Saitoh T; Kagaya T; Takebe T; Ishii K
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2168-74. PubMed ID: 6307180
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Combination therapy with estrogen and UFT in newly diagnosed prostatic cancer (poorly differentiated, stage D2)].
    Kondo I; Miura T; Fujii H; Harada M; Fukushima S; Kubota Y; Hosaka M
    Hinyokika Kiyo; 1996 Mar; 42(3):201-6. PubMed ID: 8619389
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [5-FU concentration in the serum and the tumor tissue after administration of UFT 200 mg/day to patients over 80 years of age with oral cancer].
    Iida A; Takagi R; Hoshina H; Ono K; Kaji M; Tsurumaki H; Fukuda J; Nagashima K; Miyaura Y; Hayatsu M; Miyamoto T
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1527-32. PubMed ID: 11015997
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Blood levels of 5-FU and uracil on additional use of uracil in UFT therapy in gastrectomized patients].
    Suda Y; Uchida K
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1343-7. PubMed ID: 7668868
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [A multicenter cooperative study on supplementary chemotherapy of uterocervical cancer. The Kyushu UFT Study Group of Uterocervical Cancer].
    Kato T; Yakushiji M; Yamabe T; Sugimori H; Hidaki T; Tsukamoto N; Tazaki T
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1221-7. PubMed ID: 8031165
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Contrasting effects of extended low dose versus standard dose shorter course UFT chemotherapy on microscopic versus macroscopic established tumors: implications for optimal postoperative adjuvant chemotherapy.
    Uchida J; Okabe H; Nakano K; Fujioka A; Saito H; Sugimoto Y; Oka T; Fukushima M
    Oncol Rep; 2007 Aug; 18(2):313-9. PubMed ID: 17611650
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dramatic response to uracil-tegafur (UFT) in an elderly patient with nonsmall cell lung cancer.
    Kanaji N; Bandoh S; Ishida T
    South Med J; 2007 Oct; 100(10):1056-7. PubMed ID: 17943058
    [No Abstract]   [Full Text] [Related]  

  • 68. Endocrine plus uracil/tegafur therapy for prostate cancer.
    Ono Y; Ohshima S; Takahashi Y; Kuriyama M; Kawada Y; Shimizu H
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):120-4. PubMed ID: 10442379
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Antitumor effect of UFT against differentiated thyroid cancer].
    Suzumura K; Koike A; Naruse T; Matsumoto K; Nagata H; Kojima T; Kanemitsu T; Katoh K
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2485-9. PubMed ID: 7944495
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adjuvant chemotherapy with tegafur/uracil administration after transcatheter arterial chemoembolization for advanced hepatocellular carcinoma.
    Ueda H; Tanaka H; Kida Y; Fukuchi H; Ichinose M
    Oncol Rep; 2008 May; 19(5):1355-61. PubMed ID: 18425398
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Effect of Tegafur-Uracil on Survival in T Categories as Defined in the Eighth Edition of the TNM Classification: An Exploratory Analysis of Postoperative Adjuvant Tegafur-Uracil on Survival in Patients with Adenocarcinoma of the Lung.
    Tsuboi M; Hamada C; Kato H; Ohta M
    Chemotherapy; 2017; 62(6):357-360. PubMed ID: 28817813
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [A sensitivity test of UFT and FT-207 against human pulmonary cancer using nude mice].
    Urabe N; Momiki S; Shiba M; Yamaguchi Y
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2224-8. PubMed ID: 3136694
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A randomized consent design trial of neoadjuvant chemotherapy with tegafur plus uracil (UFT) for gastric cancer--a single institute study.
    Nio Y; Koike M; Omori H; Hashimoto K; Itakura M; Yano S; Higami T; Maruyama R
    Anticancer Res; 2004; 24(3b):1879-87. PubMed ID: 15274369
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma.
    Ikeda M; Okusaka T; Ueno H; Morizane C; Furuse J; Ishii H
    Jpn J Clin Oncol; 2005 Aug; 35(8):439-43. PubMed ID: 16024530
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
    Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y
    J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of 5-fluorouracil-related gene expression levels between adenocarcinomas and squamous cell carcinomas of the lung.
    Ishihama H; Chida M; Araki O; Karube Y; Seki N; Tamura M; Umezu H; Honma K; Masawa N; Miyoshi S
    Jpn J Clin Oncol; 2009 Jan; 39(1):33-6. PubMed ID: 19015148
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
    Kato H; Ichinose Y; Ohta M; Hata E; Tsubota N; Tada H; Watanabe Y; Wada H; Tsuboi M; Hamajima N; Ohta M;
    N Engl J Med; 2004 Apr; 350(17):1713-21. PubMed ID: 15102997
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dihydropyrimidine dehydrogenase activity during long-term adjuvant treatment with oral uracil and tegafur for colorectal cancer.
    Sadahiro S; Suzuki T; Maeda Y; Ishikawa K; Tanaka Y; Yasuda S; Kamijo A; Makuuchi H; Murayama C
    Chemotherapy; 2007; 53(6):442-5. PubMed ID: 17952005
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [A case of multiple lung metastases of sigmoid colon cancer responding well to oral UFT+leucovorin therapy].
    Fukasawa M; Kitahama S; Watanabe Y; Kitagawa M; Yamamoto S; Koneri K; Kusanagi H; Kuroki M; Takeshi A; Kano N
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1967-70. PubMed ID: 16282737
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 5-FU improves p27-related poor prognosis in patients with Astler-Coller B2-C colorectal carcinoma.
    Kobayashi M; Shiraishi T; Tonouchi H; Miki C; Kusunoki M
    Oncol Rep; 2002; 9(1):29-33. PubMed ID: 11748451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.